0001421642-14-000001.txt : 20140205 0001421642-14-000001.hdr.sgml : 20140205 20140205155438 ACCESSION NUMBER: 0001421642-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140205 DATE AS OF CHANGE: 20140205 EFFECTIVENESS DATE: 20140205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICO THERAPEUTICS INC CENTRAL INDEX KEY: 0001421642 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-211358 FILM NUMBER: 14576128 BUSINESS ADDRESS: STREET 1: 760-777 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6Z 1S4 BUSINESS PHONE: 604-602-9414 MAIL ADDRESS: STREET 1: 760-777 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6Z 1S4 D 1 primary_doc.xml X0707 D LIVE 0001421642 ICO THERAPEUTICS INC 760-777 HORNBY STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6Z 1S4 604-602-9414 BRITISH COLUMBIA, CANADA None None Corporation true Andrew J. Rae 760-777 HORNBY STREET Vancouver A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Executive Officer Director William Jarosz 760-777 HORNBY STREET Vancouver A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Director Richard Barker 760-777 HORNBY STREET Vancouver A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Director Noel Hall 760-777 HORNBY STREET Vancouver A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Director Douglas G. Janzen 760-777 HORNBY STREET Vancouver A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Director Peter Hnik 760-777 HORNBY STREET Vancouver A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Executive Officer W. John Meekison 760-777 HORNBY STREET Vancouver A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Executive Officer Pharmaceuticals No Revenues 06b false 2014-01-27 true true true true true Each unit is comprised of one common share and three-quarters of one share purchase warrant. Each whole warrant is exercisable for one common share at an exercise price of Cdn$0.539 for a period of five years. false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue, 4th Floor New York NY NEW YORK 10022 NY NEW YORK false 7930682 2027393 5903289 The additional $5,903,289 may be received by the exercise of share purchase warrants sold inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada noon rate of exchage reported on January 27, 2014, which was Cdn$1.1098=US$1.00. false 2 266096 true 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false ICO THERAPEUTICS INC /s/ John Meekison John Meekison Chief Financial Officer 2014-02-04